Ann Metz

Abstract sculptural painter, vocalist, songwriter, and sometimes actor. Weekly correspondent for @manonthepen

[Ann Metz @AuntHambone]

Tune in to @ManOnThePen this morning @ 11AM CT / 12PM ET https://t.co/91B9I5UUSn

[On The Pen™ @ManOnThePen]

Zepbound VS Cagrisema: Novo BESTED Lilly? Not so Fast… https://t.co/5kJsOUEoLT

[On The Pen™ @ManOnThePen]

@DaveARicks welcome to X! Patients in our community would love to know more about the additional savings some of us were able to take advantage of last week… As well as whether or not this is a preview of an upcoming price drop. Patients shouldn’t have to speculate month to month on what the cost of their meds will be.

[On The Pen™ @ManOnThePen]

Zepbound Price Glitch: Amazon Responds to On The Pen $LLY $AMZN https://t.co/ujx8JcOgTZ

[On The Pen™ @ManOnThePen]

Retatrutide VS Tirzepatide at a glance…

Those side effect numbers for retatrutide are no joke…

Went a little deeper in the article below…

$LLY

[TODAY @TODAYshow]

Some patients taking GLP-1 weight-loss drugs report less pleasure and excitement in life. “It is not in their heads,” doctor says. How to get help if you’re feeling less joy on the medication. https://t.co/NsqNgc0OrO

[On The Pen™ @ManOnThePen]

Hey friends! Just a heads up, I will be on the @TODAYshow on @nbc this morning at 8 Eastern, discussing my experience with anhedonia on high doses of GLP-1! Tune in and let me know what you think of the piece! Hope it turned out well!

[On The Pen™ @ManOnThePen]

ELORALINTIDE HITS THE GRAY MARKET! https://t.co/2KmDXIviBv

[Ann Metz @AuntHambone]

https://t.co/NvR1pvgaNe

[On The Pen™ @ManOnThePen]

Big Week in GLP-1 https://t.co/7wApEZ1FZk

[On The Pen™ @ManOnThePen]

MEET THE QUINTUPLE AGONIST 5 Receptor Obesity Drug! $LLY $NVO $VKTX https://t.co/pgKiFx5EYf

[On The Pen™ @ManOnThePen]

🚨 BREAKING @EliLillyandCo NEWS:

$LLY will release animal study data for at QUINTUPLE AGONIST at #ADA2026

For reference:
Tirzepatide = GLP1/GIP
Retatrutide = GLP1/GIP/Glucagon
New Mol = GLP1/GIP/Glucagon/Amylin/Calcitonin

Early rat studies outperformed retatrutide!

[On The Pen™ @ManOnThePen]

COMPOUND TIRZEPATIDE: SECOND 503B BPI SHUTS DOWN GLP1 https://t.co/QPUFnywZ2K

[On The Pen™ @ManOnThePen]

👇👇👇 DON’T MISS!!! 👇👇👇

🚨 🚨 Emergency Livestream with @lawliepop at 2:00pm eastern on the impact of now 2 massive 503B compounders HALTING GLP-1 production at the request of the @US_FDA

Also @EliLillyandCo vs @mochihealth lawsuit moves forward!!

Will stream here and YouTube!

[On The Pen™ @ManOnThePen]

GLP-1 Medicare UPDATE: CVS Causes CHAOS! https://t.co/lwq6uAqfVl

[Ann Metz @AuntHambone]

RT @ManOnThePen: 🚨 REPORT ( $LLY $NVO ):
Officials from CMS have reportedly verified that the BRIDGE program (originally designed as a solu…

[On The Pen™ @ManOnThePen]

Tomorrow’s podcast on retatrutide is going to be huge.

Don’t miss it. Follow it quick right now so you don’t miss it.

$LLY

[On The Pen™ @ManOnThePen]

https://t.co/nYazPSYYp9

[On The Pen™ @ManOnThePen]

FAKE MOUNJARO!? $LLY https://t.co/rG7TaKEwzk

[On The Pen™ @ManOnThePen]

NEW ZEPBOUND RIVAL RAISES $650 MILLION! $LLY $NVO $KLRA $VKTX https://t.co/KqbC4mPPQc